Sponsor hub

The University of Texas Health Science Center, Houston clinical trial failures

Review 62 stopped clinical trials from The University of Texas Health Science Center, Houston, including disease areas, phases, and classified stop reasons.

This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 0 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.

Total stopped trials62
Likely biological signals0
Shown below62

Dominant stop reasons

OPERATIONAL
41
OTHER/UNKNOWN
21

Notable sponsors

The University of Texas Health Science Center, Houston
62

Related phases

Phase II
26
Phase IV
20
Phase I
8
Unknown
6
Early Phase I
2

Crawlable stopped-trial records

Open Explore

Showing up to 62 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.

NCT03526588: Umbilical Cord Blood Mononuclear Cells for Hypoxic Neurologic Injury in Infants With Congenital Diaphragmatic Hernia (CDH)

Phase I Congenital Diaphragmatic Hernia trial by The University of Texas Health Science Center, Houston. Stop reason: OPERATIONAL.

Competing randomized trial of an experimental therapy limited initial enrollment. The trial was completed, published, and the experimental therapy became broadly desired. Given this, the investigators felt it best to terminate this competing study.

NCT04430959: Candesartan as an Adjunctive Treatment for Bipolar Depression

Early Phase I Bipolar Disorder Depression trial by The University of Texas Health Science Center, Houston. Stop reason: OPERATIONAL.

The reason the study was withdrawn was due to lack of funds. In addition, the PI is moving to a different institution and it would not be feasible to proceed with the study under these circumstances.

NCT02882711: The UTHealth Ketamine Project

Phase II Treatment Resistant Depression trial by The University of Texas Health Science Center, Houston. Stop reason: OTHER/UNKNOWN.

Increasing off-label practice of IV ketamine administration for treatment-resistant depression.